Tamiflu Distribution Survey Question Title * 1. How difficult would it be for your practice to provide Tamiflu to affected patients without creating a risk for your staff and other patients? 1. Very difficult 2. Difficult 3. Challenging but achieveable 4. Not difficult 5. Easy 1-Very difficult to 5-Easy 1-Very difficult to 5-Easy 1. Very difficult 1-Very difficult to 5-Easy 2. Difficult 1-Very difficult to 5-Easy 3. Challenging but achieveable 1-Very difficult to 5-Easy 4. Not difficult 1-Very difficult to 5-Easy 5. Easy Question Title * 2. Do you support the following suggestions? Yes No National reserve antivirals to be held at pharmacies and made available through a pharmacist consultation National reserve antivirals to be held at pharmacies and made available through a pharmacist consultation Yes National reserve antivirals to be held at pharmacies and made available through a pharmacist consultation No Antivirals to be available via nurse consultation Antivirals to be available via nurse consultation Yes Antivirals to be available via nurse consultation No Antivirals to be supplied to third parties (similar to the ‘flu friends’ system used in the UK) to avoid the ill person having to travel to a GP or pharmacy Antivirals to be supplied to third parties (similar to the ‘flu friends’ system used in the UK) to avoid the ill person having to travel to a GP or pharmacy Yes Antivirals to be supplied to third parties (similar to the ‘flu friends’ system used in the UK) to avoid the ill person having to travel to a GP or pharmacy No Antivirals to be supplied prospectively to people at very high risk, to be taken if symptoms develop Antivirals to be supplied prospectively to people at very high risk, to be taken if symptoms develop Yes Antivirals to be supplied prospectively to people at very high risk, to be taken if symptoms develop No Antivirals to be supplied following phone consultation Antivirals to be supplied following phone consultation Yes Antivirals to be supplied following phone consultation No Please provide comments on any of the suggestions above Question Title * 3. Can you suggest some other practical methods for distributing Tamiflu to patients who need it while minimising risk of transmission to practice staff, and other patients? Question Title * 4. What challenges and issues do you think you might face with your suggested method(s)? Done
